未登录.png)
分享.png)
收藏分享 收藏 Influence of β-adrenoceptor antagonists on the pharmacokinetics of rizatriptan, a 5-HT1B/1D agonist:: differential effects of propranolol, nadolol and metoprolol
Goldberg, MR; Sciberras, D; De Smet, M; Lowry, R; Tomasko, L; Lee, Y; Olah, TV; Zhao, J; Vyas, KP; Halpin, R; Kari, PH; James, I 分享 收藏 Design and synthesis of novel α1a adrenoceptor-selective antagonists.: 2.: Approaches to eliminate opioid agonist metabolites via modification of linker and 4-methoxycarbonyl-4-phenylpiperidine moietyDhar, TGM; Nagarathnam, D; Marzabadi, MR; Lagu, B; Wong, WC; Chiu, G; Tyagarajan, S; Miao, SW; Zhang, FQ; Sun, WY; Tian, D; Shen, QR; Zhang, J; Wetzel, JM; Forray, C; Chang, RSL; Broten, TP; Schorn, TW; Chen, TB; O'Malley, S; Ransom, R; Schneck, K; Bendesky, R; Harrell, CM; Vyas, KP; Zhang, KY; Gilbert, J; Pettibone, DJ; Patane, MA; Bock, MG; Freidinger, RM; Gluchowski, C 分享 收藏 Design and synthesis of novel α1a adrenoceptor-selective antagonists.: 3.: Approaches to eliminate opioid agonist metabolites by using substituted phenylpiperazine side chainsLagu, B; Tian, D; Nagarathnam, D; Marzabadi, MR; Wong, WC; Miao, SW; Zhang, FQ; Sun, WY; Chiu, G; Fang, J; Forray, C; Chang, RSL; Ransom, RW; Chen, TB; O'Malley, S; Zhang, KY; Vyas, KP; Gluchowski, C 分享 收藏 Design and synthesis of novel α1a adrenoceptor-selective antagonists.: 1.: Structure-activity relationship in dihydropyrimidinonesNagarathnam, D; Miao, SW; Lagu, B; Chiu, G; Fang, J; Dhar, TGM; Zhang, J; Tyagarajan, S; Marzabadi, MR; Zhang, FQ; Wong, WC; Sun, WY; Tian, D; Wetzel, JM; Forray, C; Chang, RSL; Broten, TP; Ransom, RW; Schorn, TW; Chen, TB; O'Malley, S; Kling, P; Schneck, K; Bendesky, R; Harrell, CM; Vyas, KP; Gluchowski, C 分享 收藏 Design and synthesis of novel α1a adrenoceptor-selective antagonists.: 4.: Structure-activity relationship in the dihydropyrimidine seriesWong, WC; Sun, WY; Lagu, B; Tian, D; Marzabadi, MR; Zhang, FQ; Nagarathnam, D; Miao, SW; Wetzel, JM; Peng, J; Forray, C; Chang, RSL; Chen, TB; Ransom, R; O'Malley, S; Broten, TP; Kling, P; Vyas, KP; Zhang, KY; Gluchowski, C 分享 收藏 Class III antiarrhythmic activity in vivo by selective blockade of the slowly activating cardiac delayed rectifier potassium current I-Ks by (R)-2-(2,4-trifluoromethyl)-N-[2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl]acetamideSelnick, HG; Liverton, NJ; Baldwin, JJ; Butcher, JW; Claremon, DA; Elliott, JM; Freidinger, RM; King, SA; Libby, BE; McIntyre, CJ; Pribush, DA; Remy, DC; Smith, GR; Tebben, AJ; Jurkiewicz, NK; Lynch, JJ; Salata, JJ; Sanguinetti, MC; Siegl, PKS; Slaughter, DE; Vyas, K 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
